All Releases |
|
Dec 15, 2004
HARRIS & HARRIS GROUP DECLARES DEEMED DIVIDEND
|
44.0 KB
|
| |
Harris & Harris Group, Inc. announced today that its Board of Directors, in accordance with rules governing a Regulated Investment Company ("RIC") under Sub-Chapter M of the Internal Revenue Code, has declared a designated undistributed capital gain dividend (also known as a deemed dividend) for 2004.
This deemed dividend will be an amou...
|
Read more
|
|
Nov 30, 2004
HARRIS & HARRIS GROUP INVESTS IN SOLAZYME, INC.
|
42.3 KB
|
| |
Harris & Harris Group, Inc. announced today that it has invested $310,000 in Solazyme, Inc., as part of a larger funding round the company recently closed. Solazyme is a privately held company based in Menlo Park, California, and Daniel V. Leff, a Managing Director and Executive Vice President of Harris & Harris Group, Inc., has joined the Solazym...
|
Read more
|
|
Nov 15, 2004
SMALL TIMES MAGAZINE NAMES BEST OF SMALL TECH
|
59.3 KB
|
| |
Today, Small Times Magazine released its third annual performance review of the people, products and companies in micro and nanotechnology. The Awards are based on accomplishments between September 1, 2003, and October 1, 2004.
Molecular Imprints, Inc., won the Best of Small Tech Award: Company of the Year. Harris & Harris Gr...
|
Read more
|
|
Nov 8, 2004
NANTERO NAMED NANOTECHNOLOGY LEADER BY SCIENTIFIC AMERICAN
|
60.4 KB
|
| |
Shareholders of Harris & Harris Group, Inc., may be interested to know that Nantero, Inc. (www.nantero.com), has been named by Scientific American magazine as a Business Leader within the "Scientific American 50" -- the magazine's annual list recognizing outstanding acts of leadership in science and technology from the past year. Nantero ha...
|
Read more
|
|
Oct 27, 2004
HARRIS & HARRIS GROUP REPORTS BALANCE SHEET FOR NINE MONTHS ENDED SEPTEMBER 30, 2004
|
43.8 KB
|
| |
Gross assets, net assets and net asset value per share increased during the quarter, reflecting both a successful follow-on offering of the Company's shares and a successful initial public offering (IPO) of one of the Company's portfolio companies, NeuroMetrix, Inc. (Nasdaq: NURO). In the Company's oversubscribed follow-on offering, underwritten b...
|
Read more
|
|
Oct 6, 2004
NANOTECHNOLOGY ARTICLE IN BUSINESSWEEK
|
57.1 KB
|
| |
Shareholders of Harris & Harris Group, Inc. may be interested to read the article entitled, "Universe in a Grain of Sand," by Stephen Baker and Adam Aston, in the October 11, 2004, issue of BusinessWeek. The article mentions one of our portfolio companies, privately held Nantero, Inc.
Harris & Harris Group is a publicly traded v...
|
Read more
|
|
Oct 5, 2004
HARRIS & HARRIS GROUP NOTES AWARD OF SUB-CONTRACT TO NANOSYS
|
42.5 KB
|
| |
Harris & Harris Group, Inc. noted today that Nanosys, Inc. signed an $8.2 million five year sub-contract awarded by Science Applications International Corporation (SAIC) to develop undisclosed sub-system components based on Nanosys' proprietary nanotechnology platform for use in systems for the U.S. Government. Under this contract, Nanosys will re...
|
Read more
|
|
Sep 30, 2004
ARTICLE ON CHLOROGEN IN BIOVENTURE VIEW
|
57.6 KB
|
| |
Shareholders may be interested in reading the article on page 15 of the September 10, 2004 publication Bioventure View entitled, "Chlorogen: the art of pharma-synthesis." The article discusses Chlorogen's chloroplast-based protein production technology and its commercialization strategy.
Privately held Chlorogen, Inc. is develop...
|
Read more
|
|
Sep 29, 2004
HARRIS & HARRIS GROUP INVESTS IN CRYSTAL IS, INC.
|
41.0 KB
|
| |
Harris & Harris Group, Inc. announced today that it has invested $200,000 as part of a $5 million Series A Preferred round of financing by privately held Crystal IS, Inc. The investor syndicate was led by Arch Venture Partners and included JVP, 3i and Harris & Harris Group.
Crystal IS is a supplier of ultra-low defect density native a...
|
Read more
|
|
Sep 8, 2004
HARRIS & HARRIS GROUP NOTES FDA APPROVAL OF CYMBALTA
|
41.9 KB
|
| |
Harris & Harris Group, Inc. noted today that the U.S. Food and Drug Administration (FDA) has approved Eli Lilly's Cymbalta (duloxetine HCI) for the management of pain associated with diabetic peripheral neuropathic pain (DNP). DNP is a symptom of nerve damage that affects up to five million Americans, Eli Lilly announced yesterday. Cymbalta is t...
|
Read more
|
|
Aug 19, 2004
HARRIS & HARRIS GROUP NOTES AWARD OF DARPA CONTRACT TO NANOSYS
|
43.0 KB
|
| |
Harris & Harris Group, Inc., noted today that the United States Defense Advanced Research Projects Agency (DARPA) awarded a contract to Nanosys, Inc., for up to approximately $14 million over a five-year period to develop nanotechnology-enabled solar cells for power generation solutions in military applications. The initial phase of development is...
|
Read more
|
|
Aug 16, 2004
HARRIS & HARRIS GROUP NOTES NEUROMETRIX SECOND QUARTER RESULTS
|
43.5 KB
|
| |
Harris & Harris Group, Inc., noted that NeuroMetrix, Inc. (NASDAQ: NURO), reported its financial results today for the second quarter ended June 30, 2004. Revenues were $4.3 million, up 106 percent from the second quarter of 2003. Gross profit margins were 72.8 percent, versus 69.5 percent in the corresponding quarter of 2003. To view NeuroMetri...
|
Read more
|
|
Aug 10, 2004
HARRIS & HARRIS GROUP INVESTS IN NANOOPTO CORPORATION
|
41.7 KB
|
| |
Harris & Harris Group, Inc., announced today that it has invested $887,500 as part of a $3.3 million round of financing by privately held NanoOpto Corporation (www.nanoopto.com). The funding is from existing equity partners Morgenthaler Ventures; U.S. Trust's Excelsior Venture Partners III, L.L.C.; Draper Fisher Jurvetson (DFJ) Gotham Ventures and...
|
Read more
|
|
Aug 9, 2004
ARTICLE IN BARRON's
|
56.7 KB
|
| |
Shareholders of Harris & Harris Group, Inc., may be interested in reading the story in today's Barron's, on page T3, entitled, "Investors Say "Nah" to Nanosys," by Eric J. Savitz.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30, 2004, the ...
|
Read more
|
|
Aug 9, 2004
SANDRA A. MATRICK JOINS HARRIS & HARRIS GROUP AS GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
|
41.0 KB
|
| |
Harris & Harris Group, Inc., is pleased to announce that Sandra A. Matrick, J.D., has joined the firm as General Counsel, Chief Compliance Officer and Head of Human Resources. Ms. Matrick was previously an Associate in the Investment Management Group of Skadden, Arps, Slate, Meagher & Flom LLP. Ms. Matrick was graduated in the top five percent of...
|
Read more
|
|
Aug 6, 2004
ARTICLE IN FINANCIAL TIMES
|
48.9 KB
|
| |
Shareholders of Harris & Harris Group, Inc., may be interested in reading the story in today's Financial Times on page 21, entitled, "Nanosys Retreat Signals Rough Ride," by Richard Waters.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30,...
|
Read more
|
|
Aug 4, 2004
HARRIS & HARRIS GROUP NOTES WITHDRAWL OF NANOSYS IPO
|
41.1 KB
|
| |
Harris & Harris Group, Inc., noted that Nanosys, Inc., has issued a press release today noting the withdrawal of its planned IPO owing to market conditions.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30, 2004, the most recent date on which Harr...
|
Read more
|
|
Jul 30, 2004
ARTICLE ON MASS HIGH TECH.COM
|
40.3 KB
|
| |
Shareholders may be interested in reading the cover article on Mass High Tech (www.masshightech.com) entitled, "Nanotubes in space," by Matt Kelly. The article notes that Nantero, Inc. has formed a partnership with BAE Systems to explore how nanotubes might improve the performance of electronics in the aerospace and defense industries.
...
|
Read more
|
|
Jul 22, 2004
HARRIS & HARRIS GROUP NOTES NEUROMETRIX IPO
|
41.8 KB
|
| |
Harris & Harris Group, Inc., noted today that NEUROMetrix, Inc., has priced its initial public offering (IPO) of 3,000,000 shares of common stock at $8.00 per share. In 1996, Harris & Harris Group was the seed investor in NEUROMetrix, a spinout from the Harvard-M.I.T. Division of Health Science and Technology. Harris & Harris Group is the second ...
|
Read more
|
|
Jul 20, 2004
HARRIS & HARRIS GROUP REPORTS BALANCE SHEET AS OF JUNE 30, 2004
|
38.4 KB
|
| |
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 16 initial private equity investments have been in tiny-technology enabled companies. The Company has 17,248,845 ...
|
Read more
|
|
